Subjects: COLECISTOCININA, ENTEROPATIAS, MUCOSA INTESTINAL, LIPOPOLISSACARÍDEOS
ABNT
SAIA, Rafael Simone e RIBEIRO, Aline Barbosa e GIUSTI, Humberto. Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction. Shock, v. 53, n. 2, p. 242-251, 2020Tradução . . Disponível em: https://doi.org/10.1097/SHK.0000000000001355. Acesso em: 10 nov. 2024.APA
Saia, R. S., Ribeiro, A. B., & Giusti, H. (2020). Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction. Shock, 53( 2), 242-251. doi:10.1097/SHK.0000000000001355NLM
Saia RS, Ribeiro AB, Giusti H. Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction [Internet]. Shock. 2020 ; 53( 2): 242-251.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/SHK.0000000000001355Vancouver
Saia RS, Ribeiro AB, Giusti H. Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction [Internet]. Shock. 2020 ; 53( 2): 242-251.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1097/SHK.0000000000001355